Seems I am not the only one who doubts those who have stated RHC will "never" surpass $70.
http://www.eurekareport.com.au/broker-alerts/all companies
Credit Suisse upgrades RHC to Outperform from Neutral
Friday, August 28, 2015 - 15:50
Credit Suisse found Ramsay Health Care's full-year result hard to fault as revenue grew, margins expanded and cost-outs mitigated pricing risk.
The broker increases earnings per share estimates 2% beyond FY17 to reflect higher forecast operating margins in Australian hospitals after strong expansion in FY15.
CS upgrades to Outperform from Neutral and the target price rises to $72.15 from $70.75.
Target price is $72.15 Current Price is $63.68 Difference: $8.47
If RHC meets the Credit Suisse target it will return approximately 13% (excluding dividends, fees and charges).
The company's fiscal year ends in June. Credit Suisse forecasts a full year FY16 dividend of 118.13 cents and EPS of 225.08 cents. At the last closing share price the estimated dividend yield is 1.86%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is
28.29
.
(20min delay)